Plasmid-based Stat3 siRNA introduced by CaCl2 modified Hydroxyapatite (HAP) nanoparticles was able to lower the protein expression of Stat3 and p-Stat3 in prostate tumor bearing mice at the same time downregulated the expression of Stat3-associated downstream genes (170). Here, STAT3 is linked to prostate neoplasm.